New anesthesia drug may reduce breathing risks during chest operations
NCT ID NCT07347496
Summary
This study compares two anesthesia drug combinations used during chest surgery to see which is safer. Researchers want to know if a newer drug called remimazolam causes fewer breathing problems and drops in blood pressure than the commonly used drug propofol. About 50 adults having elective chest surgery will be randomly assigned to receive one of the two drug combinations while doctors carefully monitor their vital signs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANESTHESIA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.